Skip to main content

Table 1 Characteristics of the study population according to sex and hyperuricemia status

From: The visceral fat area to leg muscle mass ratio is significantly associated with the risk of hyperuricemia among women: a cross-sectional study

Characteristics Men (n = 1469) Pa Women (n = 1924) P
Non-hyperuricemia (n = 1139) Hyperuricemia (n = 330) Non-hyperuricemia (n = 1753) Hyperuricemia (n = 171)
Age, years 47.9 ± 15.7 44.4 ± 14.6 0.0002 44.0 ± 14.5 54.4 ± 16.1 < .0001
BMI, kg/m2 25.4 ± 3.2 27.0 ± 3.5 < .0001 22.8 ± 3.2 26.0 ± 3.9 < .0001
SBP, mmHg 127.0 ± 16.8 127.8 ± 15.4 0.4377 117.3 ± 18.1 129.8 ± 19.3 < .0001
DBP, mmHg 80.2 ± 10.0 83.4 ± 10.0 < .0001 75.4 ± 9.7 79.1 ± 11.5 < .0001
VFA, cm2 90.7 ± 32.8 104.9 ± 36.6 < .0001 95.1 ± 35.4 129.1 ± 41.0 < .0001
LMM, kg 17.4 ± 2.2 18.0 ± 2.2 < .0001 12.3 ± 1.6 12.5 ± 1.8 0.1409
ALT, units/L 21.6 (15.3, 31.6)b 27.3 (18.8, 45.5) < .0001 13.8 (10.0, 19.6) 18.3 (13.6, 26.0) < .0001
FPG, mmol/L 5.3 (4.9, 5.9) 5.2 (5.0, 5.7) 0.3329 5.1 (4.8, 5.4) 5.6 (5.1, 6.5) < .0001
TC, mmol/L 5.0 ± 0.9 5.2 ± 0.9 < .0001 5.1 ± 1.0 5.8 ± 1.2 < .0001
TG, mmol/L 1.3 (0.9, 1.8) 1.7 (1.2, 2.3) < .0001 1.0 (0.7, 1.4) 1.6 (1.1, 2.2) < .0001
LDL-C, mmol/L 2.6 ± 0.5 2.8 ± 0.5 < .0001 2.7 ± 0.6 3.1 ± 0.7 < .0001
HDL-C, mmol/L 1.3 ± 0.2 1.3 ± 0.2 < .0001 1.6 ± 0.3 1.5 ± 0.3 < .0001
SUA, μmol/L 336.0 ± 50.3 468.7 ± 47.1 < .0001 260.4 ± 45.8 395.3 ± 38.0 < .0001
Creatinine, μmol/L 74.7 ± 10.0 79.8 ± 11.7 < .0001 55.6 ± 7.7 61.5 ± 11.6 < .0001
Smoking, n (%) 247 (21.7) 69 (20.9) 0.7624 13 (0.7) 0 (0.0) 0.6208
Drinking, n (%) 459 (40.3) 129 (39.1) 0.6934 107 (6.1) 5 (2.9) 0.1275
Exercise, n (%)
 Never 285 (25.0) 95 (28.8) 0.1689 461 (26.3) 50 (29.2) 0.4057
 Occasional 380 (33.4) 124 (37.6) 0.1557 733 (41.8) 63 (36.8) 0.2076
 Regular 474 (41.6) 111 (33.6) 0.0091 559 (31.9) 58 (33.9) 0.5872
Hypertension, n (%) 355 (31.2) 114 (34.6) 0.2465 288 (16.4) 71 (41.5) < .0001
Diabetes, n (%) 124 (10.9) 28 (8.5) 0.2071 69 (3.9) 26 (15.2) < .0001
Dyslipidemia, n (%) 258 (22.7) 131 (39.7) < .0001 316 (18.0) 76 (44.4) < .0001
NAFLD, n (%) 473 (41.5) 211 (63.9) < .0001 405 (23.1) 116 (67.8) < .0001
Obesity, n (%) 232 (20.4) 122 (37.0) < .0001 123 (7.0) 36 (21.1) < .0001
History of diseases, n (%)
 Hypertension 367 (32.2) 111 (33.6) 0.6290 317 (18.1) 75 (43.9) < .0001
 Diabetes 116 (10.2) 23 (7.0) 0.0789 84 (4.8) 25 (14.6) < .0001
 CHD 68 (6.0) 18 (5.5) 0.7254 53 (3.0) 19 (11.1) < .0001
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, VFA visceral fat area, LMM leg muscle mass, ALT alanine aminotransferase, FPG fasting plasma glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, SUA serum uric acid, NAFLD non-alcoholic fatty liver diseases, CHD coronary heart disease
  2. Continuous variables are expressed as means ± standard deviation (SD) and categorical variables are expressed as percentages unless otherwise indicated
  3. aAnalysis of variance or chi-square test where appropriate
  4. bData are expressed as medians (interquartile range)